-
Mendelian Randomization Integrating GWAS and eQTL Data Reveals DAAM1, a Potential Immune-Related Biomarker for Breast Cancer Prognosis
16 Dec 2025 20:20 GMT
… genes (DEGs) across breast cancer molecular subtypes. (A … of DAAM1 Overexpression in Breast Cancer Tissues. (A) … aggressive, immune-resistant breast cancer subtypes.
Code Availability
The … and predicts poor prognosis in breast cancer. Pathol Res Pract …
-
AI in breast cancer screening: From mammograms to personalised risk prediction
16 Dec 2025 11:59 GMT
… high-risk populations with poorer prognosis for further intervention.'
… improving mammography screening to reduce breast cancer mortality, he specialises in developing … digital breast tomosynthesis to predict breast cancer and guide clinical care, …
-
Breaking the "Untreatable": Biostar Pharma's UTD1 Achieves First Patient Dosing in U.S. for Pivotal Clinical Trial for Breast Cancer Brain Metastases
16 Dec 2025 10:23 GMT
… for the treatment of breast cancer brain metastases.
Approximately … 20-50% of advanced breast cancer patients develop brain metastases … leading to generally poor prognoses for BCBM patients, … -clinical-trial-for-breast-cancer-brain-metastases-302643017. …
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
16 Dec 2025 03:09 GMT
… HER2-positive metastatic breast cancer
Breast cancer is the second … have improved outcomes, prognosis remains poor with … new breast cancer settings.
In HR-positive breast cancer, … negative breast cancer, an aggressive form of breast cancer, AstraZeneca …
-
ENHERTU® Plus Pertuzumab Approved in the U.S. as First New Treatment in More Than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
15 Dec 2025 20:06 GMT
… HER2 Positive Metastatic Breast Cancer
Breast cancer is the second most … including breast cancer.4 HER2 positive metastatic breast cancer is … the metastatic setting, prognosis remains poor with … :
HER2-Positive Metastatic Breast Cancer
– In combination with …
-
<![CDATA[2025 FDA Approvals Highlight Growing Role of Biomarkers in Breast Cancer]]>
13 Dec 2025 22:52 GMT
… mutations—drive differences in prognosis, treatment selection, and … of HR-positive metastatic breast cancer, and following progression, … advanced or metastatic breast cancer whose disease has progressed … ESR1-mutated metastatic breast cancer, a population with …
-
Breast Cancer Survivor Conquers 27 Triathlons with Nutrition Tips
13 Dec 2025 21:03 GMT
… . A registered dietitian who battled breast cancer in her early 40s, Burke … is linked to better cancer prognoses. In her training, she balances …
-
Pyrazoline B Induces Oxidative Stress Mediated Toxicity, Cell Cycle Arrest, and Caspase-Independent Apoptosis in BT-474 Human Breast Cancer Cells
13 Dec 2025 10:08 GMT
… breast cancer cells, 4T1 and Hs578T triple-negative breast cancer … differential sensitivity across breast cancer subtypes is particularly … and prognostic significance of VEGFR-2 in breast cancer. … of luminal B breast cancer following postoperative adjuvant …
-
<![CDATA[Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer]]>
13 Dec 2025 01:28 GMT
… metastasis and prognosis in HER2-positive breast cancer: a … or metastatic HER2 positive breast cancer (DESTINY-B12). Clinicaltrials … for metastatic HER2+ breast cancer (HER2CLIMB-05). Clinicaltrials … in patients with breast cancer brain metastases and …
-
Sentinel node biopsy may be safely skipped in early breast cancer
12 Dec 2025 22:15 GMT
… positive, HER2-negative early breast cancer.
Data showed “no … , during San Antonio Breast Cancer Symposium.
Marjolein Smidt
… procedure is more prognostic in nature with … clinically node-negative invasive breast cancer undergoing breast-conserving therapy …
About
© 1995-2025